Stock Markets September 11, 2026 08:58 AM

Celsius Holdings Shares Inch Higher After CEO Adds to Stake

Celsius stock rises in premarket trading after John Fieldly discloses purchase of 18,000 shares

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
CELH

Celsius Holdings Inc. stock moved up roughly 2% in premarket trading on Friday after Chief Executive Officer John Fieldly reported buying 18,000 shares of common stock. The Form 4 filing with the Securities and Exchange Commission shows a weighted average purchase price of $27.4357 per share, with the transactions executed in a narrow range. After the acquisition, Fieldly’s directly held beneficial ownership totals 956,063 shares, which includes a small ESPP purchase recorded on June 30.

Celsius Holdings Shares Inch Higher After CEO Adds to Stake
CELH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO John Fieldly bought 18,000 shares of Celsius common stock, triggering about a 2% premarket uptick.
  • The Form 4 filing reports a weighted average purchase price of $27.4357 per share, with transaction prices between $27.42 and $27.4387.
  • After the purchase, Fieldly’s direct beneficial ownership totals 956,063 shares, which includes 523 shares from the 2025 Employee Stock Purchase Plan on June 30 - sectors affected include consumer beverages and equity markets focused on insider activity.

Shares Rise After Insider Purchase

Celsius Holdings Inc (NASDAQ:CELH) shares traded higher in premarket activity on Friday, reflecting a roughly 2% increase following a disclosed stock purchase by Chief Executive Officer John Fieldly. The company produces and distributes functional energy drinks and liquid supplements.

Details from the Form 4 Filing

According to a Form 4 filed with the Securities and Exchange Commission, Fieldly purchased 18,000 shares of Celsius common stock on Wednesday. The filing lists a weighted average purchase price of $27.4357 per share. Individual transactions that make up the block ranged from $27.42 to $27.4387 per share, as recorded in the filing.

Post-Transaction Ownership

After completing the purchase, Fieldly’s total beneficial ownership held directly stands at 956,063 shares. That total explicitly includes 523 shares acquired under Celsius’ 2025 Employee Stock Purchase Plan on June 30, which are part of the directly held shares cited in the filing.

How the Market Interprets Insider Buying

Insider purchases such as this are commonly viewed by market participants as a sign of confidence from company executives, since they typically have access to detailed information about operations and financial condition. The filing and the subsequent price movement were the immediate facts disclosed; the filing does not by itself establish how the shares will perform going forward.

Company Profile

Celsius Holdings manufactures and distributes functional energy drinks and liquid supplements. The Form 4 and the trading reaction are the primary items reported in the filing and in market activity noted for the premarket session.


Readers should note that the information reported here is limited to the transaction details and resulting change in direct beneficial ownership disclosed in the SEC filing and the observed premarket price move.

Risks

  • An insider purchase is often seen as a confidence signal, but it does not guarantee future stock performance - this is relevant to investors and equity markets.
  • The article provides transaction details and a short-term premarket price move, but it does not include additional trading volume or long-term outlook metrics for Celsius - a limitation for market analysis.
  • Market reaction to insider buying can be short-lived or influenced by other factors not detailed in the filing or the reported premarket move - this uncertainty affects equity traders and investor sentiment.

More from Stock Markets

CrowdStrike Shares Tick Up After Analyst Boost, Backed by NVIDIA Partnership Momentum Oct 22, 2026 SPDR S&P 500 ETF Slides as Tech Earnings, Rising Oil and High Yields Trigger Risk-Off Reaction Oct 22, 2026 FDA Lifts Clinical Hold on Arbutus' AB-101, Sending Shares Higher Oct 22, 2026 Istanbul stocks climb as technology, tourism and metals lead the rally; BIST 100 up 3.22% Oct 20, 2026 Unconfirmed Qatar-Pakistan Mediation Report Boosts Equities, Pressures Oil Oct 20, 2026